Imagine the ability to prevent all strains of the flu for many years—in a single shot. In the third episode of Weizmann in Focus, CEO Dave Doneson spotlights Prof. Ruth Arnon’s remarkable progress on a universal flu vaccine. The vaccine, being brought to market by Israeli startup Biondvax, holds the promise of protecting us from current and future varieties of the virus.
Click below to watch—and please share the video with friends via email or social media.
